0.00Open0.00Pre Close0 Volume0 Open Interest2.50Strike Price0.00Turnover258.41%IV-50.88%PremiumAug 16, 2024Expiry Date2.59Intrinsic Value100Multiplier25DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.9179Delta0.0438Gamma1.83Leverage Ratio-0.0107Theta0.0013Rho1.68Eff Leverage0.0020Vega
Applied Therapeutics Stock Discussion
$Applied Therapeutics(APLT.US)$
The biopharmaceutical company said Thursday that the Food and Drug Administration now has a target action date of Nov. 28 for its application, compared with the previous date of Aug. 28.
The company's application is for govorestat in the treatment of Galactosemia, a rare genetic condition that makes patients unable to metab...
In a significant development for the healthcare sector and investors worldwide, Applied Therapeutics Inc. (NASDAQ:APLT), a clinical-stage biopharmaceutical company, has announced the Food and Drug Administration's acceptance and priority review of t...
No comment yet